DAFNA Capital Management LLC: 13F holdings
CIK 13899332026Q2
| Positions | 88 |
|---|
| Reported value | $524.4m |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 88 (+5 vs prior quarter) |
|---|
| Reported value | $524.4m (+19.3%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| RVMD REVOLUTION MEDICINES INC | 562,630 | $105.4m | 20.1% |
| XBI SPDR S&P BIOTECH ETF | 196,505 | $31.1m | 5.9% |
| CMPS COMPASS PATHWAYS PLC | 2,011,952 | $28.5m | 5.4% |
| STXS STEREOTAXIS INC | 13,680,554 | $23.5m | 4.5% |
| NKTR NEKTAR THERAPEUTICS | 318,380 | $22.2m | 4.2% |
| DNLI DENALI THERAPEUTICS INC | 739,014 | $19.0m | 3.6% |
| IDYA IDEAYA BIOSCIENCES INC | 497,240 | $18.5m | 3.5% |
| ATRC ATRICURE INC | 597,431 | $16.7m | 3.2% |
| XENE XENON PHARMACEUTICALS INC | 250,772 | $15.1m | 2.9% |
| CYTK CYTOKINETICS INC | 171,998 | $14.7m | 2.8% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1389933")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples